Dodge & Cox Adds $124M in The Cigna Group ($CI)
The investment firm added 417,173 shares of The Cigna Group, boosting its holdings to over 11.5 million shares.
Key Points
- Dodge & Cox increased its investment in The Cigna Group by 417,173 shares, now holding 11,555,787 shares worth about $3.44 billion.
- The Cigna Group, trading on the NYSE under the ticker CI, has a market cap of about $78.53 billion and a P/E ratio of 11.87.
- The company offers a dividend yield of 2.12% with an annual rate of $6.24 per share.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Dodge & Cox recently boosted its investment in The Cigna Group (NYSE:CI), adding 417,173 shares. This brings their total holdings to 11,555,787 shares, valued at approximately $3.44 billion, as per the latest Form 13F filing with the SEC. The move represents a 3.75% increase from their previous position.
What Changed in Dodge & Cox's Cigna Position
Dodge & Cox increased its stake in The Cigna Group by 417,173 shares, moving from 11,138,614 shares to 11,555,787 shares. This increase reflects a 3.75% growth in their holdings, now valued at around $3.44 billion.
The Cigna Group Stock Up 7.7%
Shares of NYSE:CI traded near $297.38. The Cigna Group has a market cap of approximately $78.53 billion, with a P/E ratio of 11.87 and a forward P/E of 8.87. The stock's beta is 0.302, indicating lower volatility compared to the market. Over the past year, the stock has ranged between $239.51 and $338.89, with moving averages of $282.08 over 50 days and $281.68 over 200 days. The company maintains a current ratio of 0.818 and a quick ratio of 0.657, with a debt-to-equity ratio of 72.81.
Recent Earnings
In its latest earnings report, The Cigna Group posted revenue of $277.89 billion, with a growth rate of 4.6%. The company's net margin stood at 2.26%, and it achieved a return on equity of 16.27%. The next earnings date is scheduled for July 30, 2026.
Earnings drift grade
Outlook vs expectations on the last report — not price action.
-
Forward outlook
6 target raises vs 3 cuts.
-
EPS & revenue
EPS missed estimates by 0.7%. Revenue met estimates.
-
Profit surprise
EBITDA met by 0 percent. Operating income met by 0 percent.
-
Pre-earnings setup
Bar was high, analysts already very bullish.
-
Analyst signal
2 downgrades, 6 target raises, 3 target cuts.
-
Earnings quality
Gross margin down 0.6 points. Positive free cash flow.
Earnings Call Summary
Cigna delivered strong first quarter results with $68.5 billion in revenue and $7.79 adjusted earnings per share, beating expectations. Specialty and Care Services drove growth at 20 percent earnings increase, while Cigna Healthcare achieved 18 percent year-over-year earnings growth. The company is exiting the individual exchange business at year end and exploring strategic alternatives for eviCore prior authorization service, sharpening focus on core high-growth platforms.
Guidance Management raised full year adjusted earnings per share guidance to at least $30.35, up from prior levels. The company plans continued investments in specialty pharmacy and new rebate-free pharmacy model called Signature, rolling out to external clients in 2028.
Neutral report. Results and guidance were close to expectations, with limited evidence of a reset either way.
Dividend
The Cigna Group offers a dividend rate of $6.24 per share, resulting in a yield of 2.12%. The dividend payout ratio is 24.36%, showing a conservative approach to dividend distribution.
About The Cigna Group
The Cigna Group, headquartered in Bloomfield, Connecticut, provides insurance and related products and services primarily in the United States. Operating through its Evernorth Health Services and Cigna Healthcare segments, the company offers a wide range of health-related services, including pharmacy benefit management and comprehensive medical plans. Led by CEO David Michael Cordani, Cigna serves a diverse customer base, including individuals, employers, and multinational organizations, through various distribution channels.
Bottom Line
Dodge & Cox's increased investment in The Cigna Group is a noteworthy development for investors tracking institutional moves. The 13F filing provides a backward-looking view of their holdings as of the reporting period, offering insight into their confidence in Cigna's performance. As always, these filings represent past actions and not necessarily current positions.
Get The Cigna Group alerts
New 13F filings, insider trades, and analyst moves on $CI, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.